Overview
- Provides an overview on the natural history of chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting toxicity
- Discusses predictors of toxicity and instruments for evaluation of CIPN symptoms
- Highlights preventive and therapeutic strategies
- Includes the patient experience of CIPN
- Serves as important resource for researchers and healthcare providers working with patients
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
-
Front Matter
Keywords
About this book
This book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes.
CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients’ experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN.
Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.
Editors and Affiliations
About the editors
Maryam Lustberg, MD: Dr. Lustberg is an Associate Professor Division of Medical Oncology at The Ohio State University, where she specializes in treating patients with breast cancer and conducts NIH-funded research at Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). She is chair on the Breast Cancer Survivorship Care Committee and is the Medical Director of Cancer Supportive Care Services. She is the President Elect of Multi National Association of Cancer Supportive Care (MASCC) and serves as Chair of MASCC Neurological Committee.
Charles L Loprinzi, MD: Dr. Loprinzi, the endowed Regis Professor of Breast Cancer Research, is a medical oncologist who has been working at Mayo Clinic in Rochester Minnesota since 1985. He has been intimately involved in symptom control research, defined as research aimed at trying to prevent and/or treat and/or better understand symptoms related to cancer and or cancer therapy. A large part of this work has involved the topic of chemotherapy-induced neuropathy. Dr. Loprinzi has been intimately involved in the conduct of 8 cooperative group randomized, placebo-controlled, double-blinded, Phase III clinical trials, 4 to try to prevent CIPN and 4 to try to treat established CIPN. He has more than 50 publications related to chemotherapy neuropathy and has served as the co-chair of the American Society of Clinical Oncology (ASCO) chemotherapy-induced peripheral neuropathy guidelines on two occasions.Bibliographic Information
Book Title: Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy
Book Subtitle: A MASCC Book
Editors: Maryam Lustberg, Charles Loprinzi
DOI: https://doi.org/10.1007/978-3-030-78663-2
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-78662-5Published: 08 October 2021
Softcover ISBN: 978-3-030-78665-6Published: 08 October 2022
eBook ISBN: 978-3-030-78663-2Published: 07 October 2021
Edition Number: 1
Number of Pages: VIII, 263
Number of Illustrations: 2 b/w illustrations, 9 illustrations in colour
Topics: Cancer Research, Neurosciences, Physiology